|
Volumn 32, Issue 5, 2004, Pages 1239-1240
|
Modulation of Inhibitor κB Kinase/Nuclear Factor κB Signaling during Critical Illness: A Double-Edged Sword [5] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
I KAPPA B KINASE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PROTEIN SUBUNIT;
TUMOR NECROSIS FACTOR ALPHA;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARTHENOLIDE;
SESQUITERPENE;
ANTIINFLAMMATORY ACTIVITY;
APOPTOSIS;
CELL DEATH;
CRITICAL ILLNESS;
DISEASE SEVERITY;
DRUG TARGETING;
ENZYME ACTIVITY;
ENZYME DEFICIENCY;
EXPERIMENTAL MODEL;
GENOTYPE;
HUMAN;
IMMUNOCOMPETENT CELL;
INFLAMMATION;
INTESTINE CELL;
INTESTINE MUCOSA;
LETTER;
LEUKOCYTE ACTIVATION;
MULTIPLE ORGAN FAILURE;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN INDUCTION;
REGULATORY MECHANISM;
SEPSIS;
SEPTIC SHOCK;
SIGNAL TRANSDUCTION;
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
TRANSCRIPTION INITIATION;
ANIMAL;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG EFFECT;
IMMUNOLOGY;
INTENSIVE CARE;
METHODOLOGY;
NOTE;
PHYSIOLOGY;
STANDARD;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CRITICAL CARE;
CRITICAL ILLNESS;
DISEASE MODELS, ANIMAL;
HUMANS;
INFLAMMATION;
MULTIPLE ORGAN FAILURE;
NF-KAPPA B;
SEPSIS;
SESQUITERPENES;
SIGNAL TRANSDUCTION;
|
EID: 18144442662
PISSN: 00903493
EISSN: None
Source Type: Journal
DOI: 10.1097/01.ccm.0000115255.43177.2c Document Type: Letter |
Times cited : (4)
|
References (0)
|